Johnson Johnson Cfo Breaks Down

Media Summary: Johnson & Johnson has $15 billion in sales at risk of erosion. On Bloomberg Chief Future Officer,

Johnson Johnson Cfo Breaks Down - Detailed Analysis & Overview

Johnson & Johnson has $15 billion in sales at risk of erosion. On Bloomberg Chief Future Officer,

Photo Gallery

Johnson & Johnson CFO breaks down mixed earnings report, full-year guidance

Johnson & Johnson is doing 'great things for patients,' CFO says

Johnson & Johnson CFO on Q2 earnings, litigation, product pipeline

Johnson & Johnson CFO breaks talc powder controversy

Johnson & Johnson CFO on earnings: Guidance has 'a lot more than meets the eye'

J&J's Q1 earnings miss was because of Covid-19 vaccine: CFO Joseph Wolk

Watch CNBC's full interview with Johnson & Johnson CFO Joseph Wolk

Johnson & Johnson CFO Dominic Caruso: We Price Our Products Responsibly | CNBC

Johnson & Johnson posts earnings beat, CFO discusses vaccine trials

Johnson & Johnson CFO Dominic Caruso: Pharma Business Continues 'Stellar' Results | CNBC

Johnson & Johnson CFO on Q2 earnings beat

Johnson & Johnson CFO on why the company is splitting into 2 separate companies